nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Decreased night vision—Tretinoin—peripheral nervous system neoplasm	0.114	0.115	CcSEcCtD
Carteolol—Decreased night vision—Isotretinoin—peripheral nervous system neoplasm	0.114	0.115	CcSEcCtD
Carteolol—Decreased night vision—Alitretinoin—peripheral nervous system neoplasm	0.0867	0.0868	CcSEcCtD
Carteolol—Night blindness—Tretinoin—peripheral nervous system neoplasm	0.035	0.035	CcSEcCtD
Carteolol—Night blindness—Isotretinoin—peripheral nervous system neoplasm	0.035	0.035	CcSEcCtD
Carteolol—Night blindness—Alitretinoin—peripheral nervous system neoplasm	0.0265	0.0265	CcSEcCtD
Carteolol—Keratitis—Tretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Carteolol—Keratitis—Isotretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Carteolol—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.00965	0.00967	CcSEcCtD
Carteolol—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.00965	0.00967	CcSEcCtD
Carteolol—Keratitis—Alitretinoin—peripheral nervous system neoplasm	0.00963	0.00964	CcSEcCtD
Carteolol—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.00894	0.00896	CcSEcCtD
Carteolol—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.00894	0.00896	CcSEcCtD
Carteolol—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.00846	0.00847	CcSEcCtD
Carteolol—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.00839	0.0084	CcSEcCtD
Carteolol—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.00839	0.0084	CcSEcCtD
Carteolol—Photophobia—Tretinoin—peripheral nervous system neoplasm	0.00773	0.00775	CcSEcCtD
Carteolol—Photophobia—Isotretinoin—peripheral nervous system neoplasm	0.00773	0.00775	CcSEcCtD
Carteolol—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.00731	0.00732	CcSEcCtD
Carteolol—Diabetes mellitus—Tretinoin—peripheral nervous system neoplasm	0.00687	0.00689	CcSEcCtD
Carteolol—Diabetes mellitus—Isotretinoin—peripheral nervous system neoplasm	0.00687	0.00689	CcSEcCtD
Carteolol—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.00677	0.00679	CcSEcCtD
Carteolol—Cardiac failure congestive—Isotretinoin—peripheral nervous system neoplasm	0.00659	0.00661	CcSEcCtD
Carteolol—Cardiac failure congestive—Tretinoin—peripheral nervous system neoplasm	0.00659	0.00661	CcSEcCtD
Carteolol—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.00636	0.00637	CcSEcCtD
Carteolol—Visual disturbance—Tretinoin—peripheral nervous system neoplasm	0.00631	0.00632	CcSEcCtD
Carteolol—Visual disturbance—Isotretinoin—peripheral nervous system neoplasm	0.00631	0.00632	CcSEcCtD
Carteolol—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.00613	0.00614	CcSEcCtD
Carteolol—Cerebrovascular accident—Tretinoin—peripheral nervous system neoplasm	0.0061	0.00611	CcSEcCtD
Carteolol—Cerebrovascular accident—Isotretinoin—peripheral nervous system neoplasm	0.0061	0.00611	CcSEcCtD
Carteolol—Photophobia—Alitretinoin—peripheral nervous system neoplasm	0.00586	0.00587	CcSEcCtD
Carteolol—Diabetes mellitus—Alitretinoin—peripheral nervous system neoplasm	0.00521	0.00522	CcSEcCtD
Carteolol—Bronchospasm—Tretinoin—peripheral nervous system neoplasm	0.00508	0.00509	CcSEcCtD
Carteolol—Bronchospasm—Isotretinoin—peripheral nervous system neoplasm	0.00508	0.00509	CcSEcCtD
Carteolol—Bronchospasm—Melphalan—peripheral nervous system neoplasm	0.00502	0.00503	CcSEcCtD
Carteolol—Cardiac failure congestive—Alitretinoin—peripheral nervous system neoplasm	0.005	0.00501	CcSEcCtD
Carteolol—Visual disturbance—Alitretinoin—peripheral nervous system neoplasm	0.00478	0.00479	CcSEcCtD
Carteolol—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Carteolol—Cerebrovascular accident—Alitretinoin—peripheral nervous system neoplasm	0.00462	0.00463	CcSEcCtD
Carteolol—Depression—Tretinoin—peripheral nervous system neoplasm	0.00459	0.0046	CcSEcCtD
Carteolol—Depression—Isotretinoin—peripheral nervous system neoplasm	0.00459	0.0046	CcSEcCtD
Carteolol—Conjunctivitis—Tretinoin—peripheral nervous system neoplasm	0.00448	0.00449	CcSEcCtD
Carteolol—Conjunctivitis—Isotretinoin—peripheral nervous system neoplasm	0.00448	0.00449	CcSEcCtD
Carteolol—Sinusitis—Tretinoin—peripheral nervous system neoplasm	0.00432	0.00433	CcSEcCtD
Carteolol—Sinusitis—Isotretinoin—peripheral nervous system neoplasm	0.00432	0.00433	CcSEcCtD
Carteolol—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.0043	0.00431	CcSEcCtD
Carteolol—Cardiac failure congestive—Cisplatin—peripheral nervous system neoplasm	0.00426	0.00427	CcSEcCtD
Carteolol—Keratitis—Epirubicin—peripheral nervous system neoplasm	0.00421	0.00422	CcSEcCtD
Carteolol—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Carteolol—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Carteolol—Cerebrovascular accident—Cisplatin—peripheral nervous system neoplasm	0.00394	0.00395	CcSEcCtD
Carteolol—Cardiac failure congestive—Etoposide—peripheral nervous system neoplasm	0.0039	0.00391	CcSEcCtD
Carteolol—Keratitis—Doxorubicin—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Carteolol—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00385	0.00386	CcSEcCtD
Carteolol—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Carteolol—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Carteolol—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Carteolol—Depression—Alitretinoin—peripheral nervous system neoplasm	0.00348	0.00349	CcSEcCtD
Carteolol—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00339	0.0034	CcSEcCtD
Carteolol—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00339	0.0034	CcSEcCtD
Carteolol—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00339	0.0034	CcSEcCtD
Carteolol—Depression—Vincristine—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Carteolol—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Carteolol—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00323	0.00324	CcSEcCtD
Carteolol—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00323	0.00324	CcSEcCtD
Carteolol—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00319	CcSEcCtD
Carteolol—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00319	CcSEcCtD
Carteolol—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Carteolol—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Carteolol—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00303	CcSEcCtD
Carteolol—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Carteolol—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00296	0.00297	CcSEcCtD
Carteolol—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Carteolol—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Carteolol—Oedema—Melphalan—peripheral nervous system neoplasm	0.0029	0.00291	CcSEcCtD
Carteolol—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00289	0.0029	CcSEcCtD
Carteolol—Shock—Tretinoin—peripheral nervous system neoplasm	0.00289	0.0029	CcSEcCtD
Carteolol—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00289	0.0029	CcSEcCtD
Carteolol—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Carteolol—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.0028	0.00281	CcSEcCtD
Carteolol—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Carteolol—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Carteolol—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00274	0.00275	CcSEcCtD
Carteolol—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Carteolol—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00271	0.00272	CcSEcCtD
Carteolol—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Carteolol—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Carteolol—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00264	0.00265	CcSEcCtD
Carteolol—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.00263	CcSEcCtD
Carteolol—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00262	0.00263	CcSEcCtD
Carteolol—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Carteolol—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Carteolol—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00257	0.00258	CcSEcCtD
Carteolol—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00257	0.00258	CcSEcCtD
Carteolol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Carteolol—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00242	CcSEcCtD
Carteolol—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.0024	0.00241	CcSEcCtD
Carteolol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Carteolol—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Carteolol—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Carteolol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Carteolol—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00219	0.0022	CcSEcCtD
Carteolol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.0022	CcSEcCtD
Carteolol—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Carteolol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00218	0.00219	CcSEcCtD
Carteolol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Carteolol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Carteolol—Oedema—Vincristine—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Carteolol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Carteolol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Carteolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Carteolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Carteolol—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Carteolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00208	0.00209	CcSEcCtD
Carteolol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00209	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00203	0.00204	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00203	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00202	0.00203	CcSEcCtD
Carteolol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00201	0.00202	CcSEcCtD
Carteolol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Carteolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Carteolol—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00199	CcSEcCtD
Carteolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Carteolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00194	0.00195	CcSEcCtD
Carteolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.00195	CcSEcCtD
Carteolol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Carteolol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Carteolol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00187	0.00188	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00188	CcSEcCtD
Carteolol—Headache—Topotecan—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Carteolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Carteolol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00184	CcSEcCtD
Carteolol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00178	CcSEcCtD
Carteolol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Carteolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Carteolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Carteolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Carteolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00172	0.00173	CcSEcCtD
Carteolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00172	0.00173	CcSEcCtD
Carteolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00169	0.0017	CcSEcCtD
Carteolol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00164	CcSEcCtD
Carteolol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00162	0.00163	CcSEcCtD
Carteolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Carteolol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Carteolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Carteolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Carteolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00148	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00144	CcSEcCtD
Carteolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Carteolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Carteolol—Nadolol—ABCB1—peripheral nervous system neoplasm	0.0014	0.745	CrCbGaD
Carteolol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Carteolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00138	CcSEcCtD
Carteolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Carteolol—Headache—Vincristine—peripheral nervous system neoplasm	0.00134	0.00135	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Carteolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00133	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Carteolol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Carteolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.00127	0.00128	CcSEcCtD
Carteolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00123	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Carteolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00114	CcSEcCtD
Carteolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Carteolol—Headache—Etoposide—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Carteolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Carteolol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Carteolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Carteolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000991	0.000993	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000976	0.000978	CcSEcCtD
Carteolol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000975	0.000976	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000971	0.000973	CcSEcCtD
Carteolol—Shock—Epirubicin—peripheral nervous system neoplasm	0.000959	0.000961	CcSEcCtD
Carteolol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000911	0.000912	CcSEcCtD
Carteolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000902	0.000903	CcSEcCtD
Carteolol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000887	0.000889	CcSEcCtD
Carteolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000881	0.000883	CcSEcCtD
Carteolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000869	0.000871	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000843	0.000844	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000816	0.000817	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000805	CcSEcCtD
Carteolol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000719	CcSEcCtD
Carteolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000699	0.000701	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000666	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000647	0.000648	CcSEcCtD
Carteolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000644	0.000646	CcSEcCtD
Carteolol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000611	0.000612	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.000597	CcSEcCtD
Carteolol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000579	0.00058	CcSEcCtD
Carteolol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000566	CcSEcCtD
Carteolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000537	CcSEcCtD
Carteolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.000481	0.255	CrCbGaD
